Mesoblast Limited American Depositary Shares (MESO) is a publicly traded Healthcare sector company. As of July 10, 2026, MESO trades at $14.95 with a market cap of $1.91B and a P/E ratio of 0.00. MESO moved +0.20% today. Year to date, MESO is -17.79%; over the trailing twelve months it is +41.10%. Its 52-week range spans $9.61 to $22.00. Analyst consensus is buy with an average price target of $35.00. Rallies surfaces MESO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for MESO, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $14.95 |
| Market Cap | $1.91B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.00 |
| 52-Week Low | $9.61 |
| Volume | 213.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover MESO: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $35.00.